Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares -January 08, 2024 at 04:06 pm EST

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the closing of its...

Related Keywords

Edgewood ,New York ,United States ,Encephalopathies Dees ,Wedbush Pacgrow ,Citigroup ,Broadridge Financial Solutions ,Longboard Pharmaceuticals ,Nasdaq ,Longboard Pharmaceuticals Inc ,Hc Wainwright Co ,Exchange Commission ,Cantor Fitzgerald Co ,Cantor Fitzgerald ,Capital Markets ,Island Avenue ,Epileptic Encephalopathies ,Private Securities Litigation Reform Act ,Markets ,